2-NITROPROPANE
Explanation
This extraction solvent has been previously considered by the
Joint FAO/WHO Expert Committee on Food Additives in 1979 (see Annex,
Ref. 54). No toxicological monograph was issued. Since the previous
evaluation, data have become available and are summarized and
discussed in the following monograph.
BIOLOGICAL DATA
BIOCHEMICAL ASPECTS
Ingestion of either 2-nitropropane or 1-nitropane by rabbits
resulted in the formation of nitrite (Scott, 1963). Metabolism to
acetone and nitrite is effected in the liver (Ullrich et al., 1978).
Groups of 8-10 Wistar rats were administered 2-nitropropane by
intraperitoneal injection or inhalation. Injection of 1.7 g/kg caused
death in two hours and 89% blood methemoglobin. Quantities of nitrite
(1-2.5 mg/100 g tissue) were found in the heart, lungs, kidney,
spleen, and liver. 2-nitropropane was found in the liver at
1.34 mg/100 g of tissue. There was no trace in the other organs and
pulmonary excretion amounted to 76% of the injected dose. Injection of
0.11 g/kg/day for 15 days followed by killing the rats 36 hours after
the last injection produced no methemoglobin, but nitrite was found in
all organs examined except the liver. 2-nitropropane was found in the
liver and lungs at concentrations of 18.7 and 360 mg/100 g tissue,
respectively. Urinary excretion of nitrite was also noted. When groups
of rats inhaled 2-nitropropane in air at 80 ppm (0.008%) for eight
hours per day and were killed the day after the fifth exposure,
methemoglobin was not detected, but nitrite was found in all organs
examined except the liver. No nitrite was detected in the urine during
the whole exposure period and no trace of 2-nitropropane was found in
the organs (Dequidt et al., 1972).
In vitro studies with microsomal preparations from the induced
livers of rats show that in the presence of NADPH, nitropropane
degrades the haeme moiety of hepatic microsomal P-450 (Ivantich et
al., 1978; Sakurai, 1981).
TOXICOLOGICAL STUDIES
Special studies on carcinogenicity
A group of 125 male and 125 female Sprague-Dawley rats were
exposed to 2-nitropropane by inhalation at a concentration of 25 ppm
(0.0025%) for seven hours per day, five days per week for 22 months.
The control group also consisted of 250 rats evenly divided between
sex. The technical grade 2-nitropropane used in the study was 95.6%
pure; the remainder being other lower nitroparaffins. Representative
groups of animals were killed after 1, 3, 6, or 12 months of exposure.
All rats remaining alive after 22 months were killed for necropsy. No
exposure-related effects were found upon periodic examination of serum
and blood chemistry. At necropsy final brain, liver, kidney and body
weights were compared. Only a slight increase in relative liver
weights was apparent. This increase was significant at the P 0.05
level for the 6-month exposed animals and at the P 0.01 level for
the 22-month exposure group. Detailed microscopic examination was
performed only on liver tissue. Liver congestion was present in 1
of 125 control males versus 8 of 125 exposed. In females, the
corresponding incidence was 0 versus 7. Focal areas of hepatocellular
nodules were present in 2 of 125 control males versus 10 of 125
exposed, and 1 of 125 control females versus 3 of 124 exposed. Focal
vacuolization of hepatocyte cytoplasm was observed in 46% of exposed
males versus 18% in controls. One liver angioma was observed in a
control male and one liver adenoma in an exposed female. The authors
concluded that no significant pathologic changes or malignancies were
attributable to exposure of rats to 25 ppm (0.0025%), seven hours per
day, five days per week, for 22 months (Griffin et al., 1980).
Groups of 50 male rats and 15 male rabbits were exposed to either
27 or 207 ppm (0.0027 or 0.0207%) of 2-nitropropane seven hours per
day, five days per week for periods up to 24 weeks. Groups of equal
size were exposed to filtered air and served as controls. Ten rats
from each group were killed after 2 days, 10 days, 1 month, 3 months,
and 6 months. Five rabbits from each group were killed after 1, 3,
and 6 months. Body weight gains for both rats and rabbits at either
exposure concentration were similar to the control groups. No
discernable exposure-related effect was seen in haematological
evaluations. The liver weights were significantly elevated in the rats
exposed to 207 ppm (0.0207%) for 1, 3, and 6 months, however, those of
rabbits did not show any consistent exposure-related weight gain. No
gross or microscopic changes were apparent in rat or rabbit tissues
from the low exposure groups. Nor were any seen in rabbit tissues from
the high exposure group. However, multiple hepatocellular carcinomas
and neoplastic nodules were present in the livers from all 10 rats in
the high exposure groups after six months. Numerous focal areas of
hepatocellular hypertrophy, hyperplasia, and necrosis were seen in the
livers of the high exposure group of rats after three months. There
was also some incidence of haemorrhagic lesions in the lungs of the
high exposure group of rats. The lungs of three of five rabbits in the
high exposure group showed microscopic alterations. During the six
months of the experiment very few classical signs of toxicity were
observed in any exposure group. It should be noted that LC50 for a
six hour exposure to 2-nitropane in male rats was found to be
approximately 400 ppm (0.04%). No females died after an exposure to
580 ppm (0.058%), whereas all male rats died at this concentration
(Lewis et al., 1979).
A group of male and female rats were exposed to 2-nitropropane at
a concentration of 200 ppm (0.02%), seven hours per day, five day days
per week for up to six months. Groups were killed after 10 days, 1
month, 3 months, and 6 months. One group was held for an additional
6-month post exposure period. Morphological changes occurred more
extensively in males and included hepatocellular nodules, hyperplasia,
necroses, and multivacuolated fatty metamorphosis. The livers of six
of 10 rats had pre-neoplastic loci and in nine out of 10 rats that
were held six months postexposure metastasizing tumours were apparent.
A similar, though not as severe, pathology was encountered after
exposing rats to 2-nitropropane at a concentration of 100 ppm (0.01%)
for 18 months. Hepatocellular carcinoma occurred in males after 12
months of exposure and in females after 18 months (Griffin et al.,
1978; Griffin et al., 1980).
Special studies on mutagenicity
The mutagenic activity of 2-nitropropane was studied in the
Salmonella typhimurium (Ames) test with and without microsomal
activation (Hite & Skeggs, 1979). A dose-related increase in
revertants was found in all four tester strains. The increase in
revertants was significant in all four strains tested and was enhanced
in the presence of microsomal preparations. However, negative results
were obtained in the mouse micronucleus test.
In another study, mutagenic activity with microsomal activation
of 2-nitropropane was shown in S. typhimurium strains TS-98 and
TA-100. Repeat tests in TA-98 using higher concentrations
(10-20 µl/plate) confirmed the mutagenic effect (Brusick, 1977).
Special studies on reproduction
A group of adult female Sprague-Dawley rats were injected i.p.
with 170 mg/kg bw of 2-nitropropane on days 1-15 of gestation. Litters
were examined one day prior to parturition. A 1-2 day retardation of
heart development was observed in pups from nine out of 10 litters
(Harris et al., 1979).
Acute toxicity
Animal Route Lethal dose Reference
Rat Oral LD50 725 mg/kg IMC, 1977
Inhl LCLo 1513 ppm (0.1513%)/ Treon & Dutra 1952
4.5 h
Inhl LC50 3712 ppm (0.3712%)/ IMC, 1979
1h
(Males) Inhl LC50 400 ppm (0.04%)/6 h Lewis et al., 1979
Guinea-pig Inhl LCLo 4622 ppm (0.4622%)/ Treon & Dutra, 1972
5.5 h
Rabbit Oral LCLo 500 mg/kg Machle et al., 1940
Inhl LCLo 2381 ppm (0.2381%)/ Treon & Dutra, 1952
4.5 h
Cat Inhl LCLo 714 ppm (0.0714%)/ Treon & Dutra, 1952
4.5 h
Short-term studies
Rabbits and guinea-pigs were administered 2-nitropropane by the
oral (stomach tube) and inhalation routes. Progressive weakness,
ataxia, and collapse were noted as well as twitching and convulsions.
General visceral and cerebral congestion as well as some degree of
liver damage was present in all animals dying from exposure. Oedema,
cloudy swelling, fatty infiltration, and necrosis were seen in the
liver. Changes in the kidney, myocardium, and other organs and tissues
were marked by oedema, pallor and cloudy swelling (Machle, 1940).
Five species of laboratory animals were exposed by inhalation to
2-nitropropane at concentrations ranging from 83 to several thousand
ppm for up to seven hours per day until acute toxic effects were
observed. Toxic effects after acute exposure decreased in the
following order: cat, rat, rabbit, guinea-pig. Signs of toxicity
included, weakness, dyspnoea, cyanosis, prostration, convulsions, and
coma. Pathologic changes included general vascular endothelial
damage/pulmonary oedema and haemorrhage, selective disintegration of
brain neurones, and hepatocellular damage. Formation of methemoglobin
and Heinz bodies was related to the severity of the exposure. No
pathologic changes occurred after exposure to air concentrations of
328 ppm (0.0328%) or 83 ppm (0.0083%) in the tissues of rats, rabbits,
guinea-pigs, or monkeys. In the cat, 328 ppm (0.0328%) caused severe
liver damage and slight to moderate toxic degeneration of the heart
and kidneys (Treon & Dutra, 1952).
Subsequent examination of tissue sections from this study has
revealed the presence of clear cell foci in the livers of rats exposed
to air containing 328 ppm (0.0328%) of 2-nitropropane for 17 exposure
periods of seven hours each (NIOSH, 1977). These cell foci are
commonly believed to be "cytologically similar to the cellular
elements of neoplastic nodules". The proliferative nodules are known
to be induced by carcinogens and "at the least, they indicate an
increased probability for the development of hepatocellular carcinoma"
(Squire & Levitt, 1975).
OBSERVATIONS IN MAN
Five or six people exposed daily in an industrial setting to
2-nitropropane at concentrations ranging from 20-45 ppm (0.002-0045%)
complained of daily episodes of anorexia, nausea, diarrhoea, vomiting,
and occipital headaches. Two workers in another plant where the
concentration of 2-nitropropane in their breathing zone varied between
10 and 25 ppm (0.001 and 0.0025%) were apparently symptom free
(Skinner, 1947). 25 ppm (0.0025%) is the current United States
occupational exposure standard (OSHA, 1975).
An epidemiological study on 1481 employees of a Sterlington,
Louisiana production facility was completed in 1979. The study covered
the years between January 1955 and July 1977. Depending on which
department the employees worked in, classification was made into three
cohorts (direct, indirect, or no exposure). Prior to 1977, there was
no formalized monitoring system. Between 1955 and 1962 corrective
action was taken to reduce exposure based upon informal subjective
odour threshold evaluation. Between 1962 and 1977 measured
concentrations were made above 25 ppm (0.0025%). These excursions
above 25 ppm (0.0025%) were at times accompanied by symptoms of
headache and nausea. For a six-month period in 1977, 98% of 144 air
samples were below 10 ppm (0.001%) (time-weighted average). Causes of
death were coded from death certificates and compared with those
expected using age-time-cause specific mortality rates. It was
concluded that the data does not suggest any unusual cancer or disease
mortality. It was further noted: "However, both because the cohort is
small and because the period of latency (the time between first
exposure and observation) is for most relatively short, one cannot
conclude from these data that 2-NP is non-carcinogenic in humans".
Three unusual findings were also pointed out: (1) there were 4
lymphatic cancers where 0.9 was expected in the "no exposure" male
population; (2) there were 4 deaths from all cancers where 0.4 was
expected in the female population; (3) there were 7 deaths from
"sarcomatous" cancer in the "no exposure" population (Miller & Temple,
1979).
Comments
Most of the available data relates to exposure of animals to
2-nitropropane by inhalation. There is very limited acute oral data
which indicates that under these conditions of exposure, the toxic
effects are similar to those observed by the inhalation route under
acute conditions. Inhalation data clearly indicate that 2-nitropropane
is hepatoxic to rodents and at high levels of exposure there is
evidence of a carcinogenic effect. 2-nitropropane has been shown to be
mutagenic in the Ames assay. The limited human data shows that
2-nitropropane can cause headaches, anorexia, nausea, diarrhoea, and
vomiting at air concentrations as low as 20 ppm (0.002%). An
epidemiological study on a population of industrially-exposed workers
proved to be inconclusive in establishing carcinogenicity in man.
EVALUATION
This substance is unsuitable as a food additive.
REFERENCES
Brusick, D. J. (1977) Mutagenic Evaluation of P-135766459T, Final
Report, Litton Bionetics, Inc., 5516 Nicholson Lane, Kensington,
Maryland 20795
Dequidt, J., Vasseur, P. & Potencier, J. (1972) Etude toxicologique
experimentale de quelques Nitroparaffines, Bull. Soc. Pharma.
Lille, 83-87; Experimental Toxicologic Study of Some
Nitroparaffins, translation by International Minerals & Chemical
Corporation, 666 Garland Place, Des Plaines, Illinois 60016
Griffin, T. B. et al. (1978) Chronic Inhalation Toxicity of 2
Nitropropane in Rats, Pharmacologist, 20, 145
Griffin, T. B., Coulston, F. & Stein, A. A. (1980) Chronic Inhalation
Exposure of Rats to Vapors of 2-Nitropropane at 25 ppm,
Ecotoxicol. & Enviro. Safety, 4, 267-281
Harris, S. J., Bond, G. P. & Niemeier, R. W. (1979) The Effect of 2
Nitropropane, Naphthalene, and Hexachlorobutadiene on Fetal Rat
Development, Toxicol. Appl. Pharmacol., 48, A35
Hite, M. & Skeggs, H. (1979) Mutagenic Evaluation of Nitroparaffins in
the Salmonella Typhimurium/Mammalian-Microsome Test and the
Micronucleus Test, Enviro. Mutagen., 1, 383-389
IMC (1977) A Review of Toxicology Studies on the Nitroparaffins with
Particular Emphasis on 2-Nitropropane, International Minerals &
Chemical Corporation, NP Division, 666 Garland Place, Des
Plaines, Illinois, 2 pp.
IMC (1979) Review of Safety Data on 2-Nitropropane, International
Minerals & Chemical Corporation, NP Division, 666 Garland Place
Des Plaines, Illinois, 5 pp.
Ivantich, K. M. et al. (1978) Organic Compounds - Their Interaction
with and Degradation of Hepatic Microsomal Drug Metabolizing
Enzymes In Vitro, Drug Metab. Dispos., 6, 218-225
Lewis, T. R., Ulrich, C. E. & Busey, W. M. (1979) Subchronic
Inhalation Toxicity of Nitromethane and 2-Nitropropane,
J. Envir. Path. Toxicol., 2, 233-249
Machle, W., Scott, E. W. & Treon, J. (1940) The Physiological Response
of Animals to Some Simple Mononitroparaffins and to Certain
Derivatives of These Compounds, J. Ind. Hyg. Toxicol., 22,
315-332
Miller, M. & Temple, G. (1979) 2-NP Mortality Epidemiology Study of
the Sterlington, La Employees, International Minerals and
Chemical Corporation, Mundelein, Illinois
NIOSH (1977) NIOSH Current Intelligence Bulletin: 2-Nitropropane, The
National Institute for Occupational Safety and Health, U.S.
Department of Health and Human Services, Rockville, Maryland
20857
OSHA (1975) U.S. Department of Labor, Occupational Safety & Health
Administration, U.S. Code Fed. Regul., Title 29, part
1910.1000, July 1, 1975
Sakurai, H. et al. (1980) The Interaction of Aliphatic Nitro Compounds
with the Liver Microsomal Monooxygenase System, Biochem.
Pharmacol., 29, 341-345
Scott, E. W. (1943) Metabolism of Nitroparaffins, J. Ind. Hyg.
Toxicol., 25, 20-25
Skinner, J. B. (1947) The Toxicity of 2-Nitropropane, Ind. Med.,
16, 441-443
Squire, R. A. & Levitt, M. H. (1975) Report of a Workshop on
Classification of Specific Hepatocellular Lesions in Rats,
Cancer Res., 35, 3214-3215
Treon, J. F. & Dutra, F. R. (1952) Physiological Response of
Experimental Animals to the Vapor of 2-Nitropropane, Arch. Ind.
Hyg. Occup. Med., 5, 52-61
Ullrich, V., Hermann, G. & Weber, P. (1978) Nitrite Formation from 2
Nitropropane by Microsomal Monooxygenases, Biochem. Pharmacol.,
27, 2301-2304
See Also:
Toxicological Abbreviations
Nitropropane, 2- (EHC 138, 1992)
Nitropropane, 2- (WHO Food Additives Series 19)
Nitropropane, 2- (WHO Food Additives Series 26)
Nitropropane, 2- (IARC Summary & Evaluation, Volume 71, 1999)